For diabetes management, alternatives include SGLT-2 inhibitors, DPP-4 inhibitors (which should not be combined with GLP-1 medications), metformin, and insulin when necessary
V.Barrientos-PerezM.FainbergU.Frimer-LarsenH.HafezM.HaleP
People using GLP-1 medication at their standard dose may experience the full therapeutic effect, in contrast to others who are microdosing
Notably, some studies have observed that research subjects experiencing fatigue or reduced energy on sema or tirz seemed to maintain or even regain energy levels when switched to Reta
JAMIA Open 6(2):ooad035 Anson M, Zhao SS, Austin P, Ibarburu GH, Malik RA, Alam U (2023) SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study
In clinical trials of the Wegovy pill, weight loss typically continues to build over the first year of treatment, with the largest reductions usually seen around 64 weeks